20
Participants
Start Date
November 1, 2023
Primary Completion Date
June 1, 2026
Study Completion Date
June 1, 2026
Felzartamab
Administered IV
RECRUITING
Westmead Hospital, Westmead
RECRUITING
Western Health, Saint Albans
RECRUITING
Monash Health, Melbourne
RECRUITING
Princess Alexandra Hospital, Woolloongabba
RECRUITING
Joseph S. and Diane H. Steinberg Ambulatory Care Center, Brooklyn
COMPLETED
SUNY Downstate Medical Center, Brooklyn
WITHDRAWN
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City
RECRUITING
Georgia Nephrology - Lawrenceville, Lawrenceville
WITHDRAWN
Servicios Avanzados de Investigación Médica/ Mediadvance Clinical S.C., Chihuahua City
COMPLETED
ClinCept, LLC/River City Vascular Specialists LLC, Columbus
RECRUITING
The Ohio State University (OSU), Columbus
RECRUITING
University Hospitals Cleveland Medical Center, Cleveland
WITHDRAWN
Centro Integral en Reumatología S.A. de C.V., Guadalajara
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Precision Comprehensive Clinical Research Solutions - Grapevine, Grapevine
COMPLETED
Prolato Clinical Research Center, Houston
RECRUITING
Accurate Clinical Research - Katy, Katy
RECRUITING
R & H Clinical Research, Katy
WITHDRAWN
Centricity Research - Phoenix, Mesa
RECRUITING
University of California, San Diego (UCSD), La Jolla
RECRUITING
University of California, San Francisco (UCSF), San Francisco
RECRUITING
Stanford University Medical Center, Stanford
WITHDRAWN
Medical Care and Research S.A de C.V., Mérida
RECRUITING
Hospital Britanico de Buenos Aires, Caba
RECRUITING
CEMIC, CABA
RECRUITING
Clinica Priv Velez Sarsfield, Córdoba
RECRUITING
St. Paul's Hospital, Vancouver
RECRUITING
University Health Network - Toronto General Division, Toronto
RECRUITING
Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal
HI-Bio, A Biogen Company
INDUSTRY